BioMotiv, the for-profit accelerator of The Harrington Project, is the developer and lead funder for Allinaire Therapeutics. BioMotiv aims to advance a portfolio of discoveries into new medicines through an innovative, mission-driven model that efficiently aligns capital and collaborations for the benefit of inventors and investors, and ultimately physicians and patients.
Learn more about BioMotiv here.
Become a Partner
If you or your organization is interested in learning more about partnering with Allinaire Therapeutics, please contact us via the form below.